AIM ImmunoTech Achieves NYSE American Listing Compliance
AIM ImmunoTech Inc. has confirmed it is back in compliance with the NYSE American LLC's continued listing standards. The company received official notification that all previously identified deficiencies under Section 1003(a) have been resolved.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.